Capacity Building for National Immunization Programs in the Eastern Mediterranean Region

The Capacity Building for National Immunization Programs in the Eastern Mediterranean Region opportunity is a forecasted federal cooperative agreement from the U.S. Department of Health and Human Services through the Centers for Disease Control and Prevention. The opportunity number is CDC-RFA-JG-27-0070, and the Assistance Listing is 93.318, Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security. The opportunity is categorized as discretionary funding in the Health category. The forecast was dated August 31, 2026, and the program is expected to make one award with estimated total program funding of $75,000,000. The purpose of the award is to strengthen the capacity and performance of national immunization programs in countries of the Eastern Mediterranean Region. The program is intended to advance regional vaccine preventable disease control, elimination, and eradication targets, including polio eradication and measles and rubella elimination. It also seeks to reduce vaccine preventable disease related morbidity and mortality and address emerging public health threats. The recipient will strengthen capacities to prevent, detect, and respond to vaccine preventable diseases in Eastern Mediterranean Region countries. Supported work is expected to include immunization service delivery, comprehensive vaccine preventable disease surveillance, and capacity necessary to prepare for, detect, and respond to vaccine preventable disease outbreaks. The recipient will develop and implement targeted strategies to improve access to and immunization coverage among high risk un-immunized and under-immunized populations. Activities will also foster immunization program sustainability through evidence based decision making using National Immunization Technical Advisory Groups, immunization safety, and workforce capacity. Program evaluation and innovation may be used to identify and address key immunization program challenges and to strengthen the use of evidence in guiding immunization policy. The cooperative agreement may additionally support other global health priorities that align with CDC goals. No cost sharing or matching requirement applies. Eligible applicants include state, county, city or township, and special district governments; federally recognized Native American tribal governments; Native American tribal organizations other than federally recognized tribal governments; independent school districts; public housing authorities and Indian housing authorities; public and state controlled institutions of higher education; private institutions of higher education; nonprofits with or without 501(c)(3) status other than institutions of higher education; small businesses; and other for profit organizations. The forecast also identifies the opportunity as unrestricted among the listed entity types, subject to any clarification provided in additional eligibility information. No additional eligibility restrictions are stated in the supplied forecast. Although the programmatic work focuses on countries of the Eastern Mediterranean Region, the source does not provide a more specific applicant location restriction. The opportunity is currently a forecast rather than an open application. The estimated posting date is December 14, 2026, making the current stage Early Engagement. The estimated application deadline is February 12, 2027, and electronically submitted applications must be received no later than 11:59 p.m. Eastern Time on that date. The supplied forecast does not identify an LOI, concept paper, notice of intent, pre-proposal, or other pre-application gating requirement. It also does not provide application questions, required uploads, narrative components, evaluation criteria, or other detailed submission mechanics. Those details therefore cannot be established from the forecast and may be provided when the full opportunity is posted. The estimated award date is July 1, 2027, and the estimated project start date is August 1, 2027. The fiscal year is 2027, and the listed archive date is March 14, 2027. The source reports an award ceiling and award floor of zero; under the grant data rules, those values are treated as missing rather than as valid award limits, so no individual award ceiling or floor can be established from the supplied information. The source does not state that this opportunity recurs annually, biennially, quarterly, or on another regular schedule, so recurrence is not inferred. The named grantor contact is Julie Jenks at the Centers for Disease Control and Prevention. The listed email address is jdj2@cdc.gov, and the listed telephone number is (404) 718-2794. Because this is a forecasted opportunity, applicants should rely on the subsequently posted solicitation for final application requirements, evaluation criteria, allowable cost details, performance period information, and confirmed award parameters. The supplied material does not contain an explicit direct PDF URL for a NOFO, RFA, guidelines document, or application document.

Align proposed activities with the stated goals of strengthening national immunization program capacity and performance, preventing, detecting, and responding to vaccine preventable diseases, improving immunization service delivery and surveillance, preparing for outbreaks, improving access and coverage among high risk un-immunized and under-immunized populations, strengthening program sustainability and workforce capacity, and using evidence to guide immunization policy.